Evercore ISI reaffirmed its positive stance on Meta Platforms Inc. (NASDAQ: NASDAQ:META), maintaining an Outperform rating ...

Evercore ISI initiated coverage on Mid-America Apartment Communities (NYSE:MAA), a real estate investment trust (REIT) specializing in multifamily properties in the Sunbelt region, with an In Line ...

Evercore ISI expressed on Friday that Wall Street will likely see more of what it experienced in 2024, as the investment institution stated “Fill IT up again” in 2025 indicating its positive ...

Evercore ISI added United Parcel Service (NYSE:UPS) to its Tactical Outperform list ahead of the parcel delivery giant's earnings report on January 30. The firm also raised its price target on UPS ...

Shares of NYSE:VST opened at $186.79 on Tuesday. Vistra has a 52-week low of $39.13 and a 52-week high of $194.67. The stock has a market cap of $63.55 billion, a P/E ratio of 34.85, a PEG ratio ...

In a report released yesterday, John Pancari from Evercore ISI maintained a Hold rating on Comerica (CMA – Research Report), with a price target of $67.00. The company’s shares closed ...

In a report released today, Jonathan Chappell from Evercore ISI maintained a Hold rating on Union Pacific (UNP – Research Report), with a price target of $262.00. The company’s shares closed ...

NEW YORK, January 03, 2025--(BUSINESS WIRE)--Evercore (NYSE: EVR) will host its 11th annual Utility CEO Conference in Scottsdale, Arizona, Jan. 8-10, 2025. The power & utilities sector is rapidly ...

Fintel reports that on January 24, 2025, Evercore ISI Group initiated coverage of Mid-America Apartment Communities (NYSE:MAA) with a In-Line recommendation. As of December 23, 2024, the average ...

Evercore ISI also highlighted Madrigal's progress towards ... enrollment for the MAESTRO-NASH OUTCOMES trial, which evaluates resmetirom as a potential treatment for NASH cirrhosis.

Emphasizing the potential of firms positioned to profit from increased corporate use of artificial intelligence, Evercore ISI has released its top software stock recommendations for 2025.

Evercore ISI also highlighted Madrigal's progress towards European ... The company has completed patient enrollment for the MAESTRO-NASH OUTCOMES trial, which evaluates resmetirom as a potential ...